Physician profile
Steven D Evans
NPI 1669442331
$51,967.23
in general payments reported to CMS, 2019-2025
18 companies · $5,983 in 2025
The $5,983 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,271 · 2020: $2,870 · 2021: $7,500 · 2022: $6,237 · 2023: $12K · 2024: $14K · 2025: $5,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $5,299 · Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,927.45 |
| Travel and Lodging | $5,298.88 |
| Food and Beverage | $862.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $29,742.68 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| E.R. Squibb & Sons, L.L.C. | $6,339.17 | 2023 | |
| Innocoll Pharmaceuticals Limited | $2,400.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,400.00 | 2021 | |
| Amgen INC. | $2,020.12 | 2021-2024 | Uplizna |
| Kyowa Kirin, INC. | $1,929.99 | 2019 | |
| Glaxosmithkline, LLC. | $1,450.00 | 2020 | |
| Taiho Oncology, INC. | $1,420.00 | 2020 | |
| Johnson & Johnson Health Care Systems INC. | $1,125.00 | 2024 | Spravato |
| Sandoz INC. | $1,041.00 | 2019 | |
| Genzyme Corporation | $920.00 | 2022 | |
| Y-Mabs Therapeutics, INC. | $700.00 | 2021 | |
| Therapeuticsmd, INC. | $300.00 | 2019 | |
| Janssen Biotech, INC. | $69.25 | 2022-2023 | Stelara |
| Abbott Laboratories | $48.14 | 2024 | Proclaim, Eterna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $25.22 | 2022-2023 | Vumerity, Tysabri |
| Intercept Pharmaceuticals, INC. | $22.42 | 2022 | |
| Gilead Sciences, INC. | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.